| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
DRMA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 102.0K | - | - | |
| CEO | 37.5K | - | - | |
| VP | 18.0K | - | - | |
| Dir | 2.5K | - | - | |
| Dir | 2.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Scott Kathleen D.64 | Director | Sell | 11 | $1.19 | $13.09 | -100% | - | - | |
| Feb 17, 2026 | Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs | Buy | 1,000 | $1.27 | $1,270.00 | +8,333% | - | - | |
| Nov 23, 2021 | Proehl Gerald T | President, CEO And Chairman | Buy | 20,000 | $2.40 | $48,000.00 | +50.6% | -49.4% | -72.4% | |
| Aug 17, 2021 | Hale David F | Director, 10% Owner | Buy | 35,714 | $0.00 | - | New | -3.1% | -85.4% | |
| Aug 17, 2021 | Proehl Gerald T | President, CEO And Chairman | Buy | 152,857 | $0.32 | $49,631.00 | New | -3.1% | -85.4% |